GLP-1 Coverage & Costs in Delaware (2026)
$79/month (Embody, compounded semaglutide, monthly plan) is the lowest monthly-plan price we have recorded among the programs on this page. Embody lists 48 states and our records do not name them, so confirm Delaware at intake.
The lowest recorded compounded tirzepatide price is $129/month (Embody, monthly plan). Among programs recorded as available in all 50 states, the lowest is $139/month (AgelessRx, compounded semaglutide, monthly plan). 6 of the 49 programs listed have no recorded price. Recorded prices cover medication and known program fees, not a verified total.
Delaware Medicaid Coverage for GLP-1
Medicaid: covered as of January 2026 (KFF)
KFF's map lists Delaware among the 13 state programs covering GLP-1s for obesity under fee-for-service as of January 2026. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan.
- Source: KFF, Medicaid Coverage of and Spending on GLP-1s, Figure 1 (January 16, 2026). Read 2026-11-06.
Delaware Medicaid GLP-1 Prescriptions in 2025
55,674
#35
$20.1 million
Wegovy
Delaware Medicaid paid for 55,674 GLP-1 prescriptions in 2025, 0.5% of the 11.26 million paid nationally and number 35 of 51 (50 states and DC). It reimbursed pharmacies $20.1 million before manufacturer rebates, about $362 per prescription, and the most-filled product was Wegovy. These counts include diabetes prescriptions, not only weight loss. Wegovy, Zepbound and Saxenda, the brands approved for chronic weight management, made up 31,647 of those prescriptions (56.8%). Wegovy and Zepbound also carry other approved uses, so this is an upper bound on weight-loss use, not a count of it.
From 2021 to 2025, Delaware Medicaid GLP-1 prescriptions went from 12,923 to 55,674, 4.3 times the 2021 count. From 2024 to 2025 the count rose by 15,532.
12,923
19,090
32,518
40,142
55,674
| Product | DE Medicaid prescriptions, 2025 | Share |
|---|---|---|
| Wegovy | 18,765 | 33.7% |
| Ozempic | 17,134 | 30.8% |
| Zepbound | 12,784 | 23% |
| Trulicity | 3,481 | 6.3% |
| Mounjaro | 2,987 | 5.4% |
| Rybelsus | 414 | 0.7% |
| Saxenda | 98 | 0.2% |
| Bydureon | 11 | under 0.1% |
Source: CMS State Drug Utilization Data, 2025 (updated July 13, 2026), fee-for-service and managed care, all four quarters, compiled in our network's PriceTracker GLP-1 state table (read October 4, 2026); 2021 to 2024 summed by us from CMS's own yearly datasets with the same method, read November 9, 2026. CMS hides rows under 11 prescriptions, so small counts are slightly low. CMS publishes no per-enrollee rate here, so a total reflects the size of the program as much as use.
Delaware Employee Plan and Insurer GLP-1 Rules
State of Delaware Group Health Insurance Plan (non-Medicare)
Covers GLP-1s for weight lossDelaware's state employee prescription plan still covers GLP-1s for weight management such as Wegovy and Zepbound. Since July 1, 2026 non-Medicare members pay a $200 copay per 30-day supply, set by the State Employee Benefits Committee on March 9, 2026.
The Statewide Benefits Office says the Committee voted on March 9, 2026 to raise the weight-management GLP-1 copay to $200 per 30-day supply.
“At the March 9, 2026 State Employee Benefits Committee (SEBC) meeting, the Committee voted to increase the copay to $200 per 30-day supply for GLP-1 medications for weight management, such as Wegovy and Zepbound*, effective July 1, 2026 for non-Medicare prescription plan participants.”
Source: Delaware Statewide Benefits Office. Read October 29, 2026.
The copay applies to every current and future drug in the class.
“The $200 copay will apply to any current and future medications in this drug class.”
Source: Delaware Statewide Benefits Office. Read October 29, 2026.
We have no Delawareinsurer policy on record yet. Most commercial plans decide GLP-1 coverage plan by plan, so the employer's choice matters as much as the insurer.
Comparing self-pay programs in Delaware?
2-minute quiz: filter by budget and medication preference.
Telehealth Programs to Check for Delaware
We list 49 programs here. 21 are recorded as available in all 50 states. 7 more publish their own state list, summarized below for Delaware. The rest record a state count without naming the states, so confirm Delaware with the program at intake before you pay.
What Programs' Own Pages Say About Delaware
8 of the 8 programs whose own pages name the states they serve include Delaware: Willow, SnagRx, Strut Health, MangoRx, Wellorithm, MEDGm, TelosRx, Trimi. Pages read November 9, 2026. This is what each seller states about availability, not a licensing check.
| Program | Delaware |
|---|---|
| Willow | Serves DE |
| SnagRx | Serves DE |
| Strut Health | Ships to DE |
| MangoRx | Ships to DE |
| Wellorithm | Serves DE |
| MEDGm | Serves DE |
| TelosRx | Serves DE |
| Trimi | Serves DE |
Trimi's state table lists Delaware as served through the Arora Health network. Visit format there: Online evaluation through the Arora Health network. The telehealth law it cites for Delaware is 24 Del. C. 6003. That citation is Trimi's, not our legal reading. Trimi state table, read November 9, 2026.
Programs on Our List, in Published Order
Compounded GLP-1 care with one-month and prepaid plans
Personalized GLP-1 consultations with tailored prescriptions and ongoing physician support
Affordable compounded semaglutide from $119/mo with free shipping and health coaching
Personalized GLP-1 weight loss with licensed providers and nationwide coverage
45 more programs on our list: 19 recorded as available in all 50 states, 7 with a state list shown in the table above, and 19 with a state count but no published list we have read. Compare all of them side by side.
Estimated GLP-1 Costs in Delaware
Telehealth (Compounded)
$79 to $399/moRecorded monthly-plan prices for compounded semaglutide and tirzepatide. Availability varies by program, so confirm your state at intake.
Wegovy
Brand prices with and without insurance.
Zepbound
List, LillyDirect and savings card prices.
No insurance
Self-pay GLP-1 options without coverage.
The compounded range is our recorded monthly-plan prices, the same in every state. Brand and insurance costs depend on the plan, so we link the pages that carry their sources. Compounded medications are not FDA-approved.
Medicare Part D GLP-1 Claims in Delaware, 2024
Delaware prescribers wrote 67,256 Medicare Part D GLP-1 claims in 2024, number 42 of 51, with $100.7 million in gross drug cost before rebates. Ozempic led with 33,326 claims for 7,514 enrollees. Wegovy had 1,007 claims. Part D did not pay for weight loss alone in 2024, so these fills are for diabetes and other approved uses.
| Product | DE Part D claims | Enrollees |
|---|---|---|
| Ozempic | 33,326 | 7,514 |
| Mounjaro | 13,541 | 2,902 |
| Trulicity | 13,396 | 3,132 |
| Rybelsus | 4,709 | 1,336 |
| Wegovy | 1,007 | 264 |
| Victoza | 618 | Not given |
| Bydureon Bcise | 450 | 130 |
| Liraglutide | 149 | 73 |
| Byetta | 60 | 13 |
Source: CMS Medicare Part D Prescribers by Geography and Drug, 2024 (updated May 21, 2026), state rows, read November 9, 2026. The state is the prescriber's. Claims include refills, and enrollees are not added across products because one person can fill two.
Medicare GLP-1 Bridge Program in Delaware
The Bridge is national, so the rules are the same in Delaware as everywhere: eligible Part D enrollees pay $50/month for Foundayo, Wegovy or Zepbound KwikPen, subject to BMI rules and exclusions. Medicare fact sheet.
$50/mo
July 1, 2026
Dec 31, 2027
How Delaware Compares to Other Mid-Atlantic States
Medicaid coverage of GLP-1s for obesity is optional for states, so the answer differs by state. Here is how Delaware and its neighbors in the Mid-Atlantic are recorded:
| State | Medicaid and GLP-1s for obesity | Medicaid GLP-1 Rx, 2025 |
|---|---|---|
| Delaware (this page) | Covered, January 2026 (KFF) | 55,674 |
| District of Columbia | Not covered | 27,754 |
| Maryland | Not covered | 148,487 |
| Virginia | Covered, January 2026 (KFF) | 227,472 |
| West Virginia | Not covered | 94,999 |
Our recorded telehealth prices are not state-specific: $79 to $399/month on monthly plans. Medicaid and marketplace coverage is what varies.
KFF counted 13 state Medicaid programs covering GLP-1s for obesity under fee-for-service as of January 2026. Managed care plans may differ. Later counts may be lower: The RX Index, an independent tracker, listed 11 in a July 10, 2026 snapshot and says that is not a current national count. Sources read November 6, 2026. Policies change, so confirm with your state Medicaid agency or plan.
If Your Insurance Denies GLP-1 Coverage in Delaware
Commercial plans offer an internal appeal, then external review; Delaware Medicaid enrollees can ask for a fair hearing. The denial letter names the deadlines.
How to Check Your Specific Plan in Delaware
- Delaware Medicaid: Medicaid: covered as of January 2026 (KFF). Ask your Medicaid plan for its drug list and prior authorization rules, or find the state agency on Medicaid.gov's state contacts.
- State employees: State of Delaware Group Health Insurance Plan (non-Medicare), covers glp-1s for weight loss per the documents cited above. Confirm with the plan before you fill a prescription.
- Any other plan: call the number on your card and ask whether Wegovy or Zepbound is covered for weight loss, which tier it sits on, and what prior authorization needs. Get the answer in writing.
Find the Right GLP-1 Provider in Delaware
Answer a few questions and we'll match you with the best GLP-1 program for your budget, insurance, and goals in Delaware.
Frequently Asked Questions — Delaware
Does Delaware Medicaid cover GLP-1 medications for weight loss?
How many GLP-1 prescriptions did Delaware Medicaid pay for in 2025?
How many Medicare Part D GLP-1 claims were there in Delaware in 2024?
Does the Delaware state employee health plan cover GLP-1s for weight loss?
What is the cheapest way to get GLP-1 medication in Delaware?
Which online GLP-1 programs serve Delaware?
Does Medicare cover GLP-1s in Delaware?
Ready to start?
Compare the recorded costs, sources and evidence gaps for 52 listed providers. Confirm current terms with the provider before enrolling.